Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DI Other cephalosporins and penems
J01DI02 Ceftaroline fosamil
D08884 Ceftaroline fosamil (USAN/INN) <US>
USP drug classification [BR:br08302]
Antibacterials
Beta-lactam, Cephalosporins
Ceftaroline Fosamil
D08884 Ceftaroline fosamil (USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01714 Cephalosporin skeleton group
DG01488 Cephem
D08884 Ceftaroline fosamil
DG01804 Oxyimino beta-lactam
D08884 Ceftaroline fosamil
Drug classes [BR:br08332]
Antibacterial
DG01488 Cephem
D08884 Ceftaroline fosamil
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
D08884 Ceftaroline fosamil (USAN/INN) <US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
D08884 Ceftaroline fosamil (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08884
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08884
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08884